PSCH Among Health Care ETFs
End-of-day Nov 20, 2026 · 39 Health care ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.3% | −4.8% | −0.3% | −2.5% | +22.8% | +29.2% | +45.0% | −14.4% | +135.3% | +568.0% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$53 of every $1,000 in PSCH is TG
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | TGTXTG Therapeutics | Healthcare | 5.26% | $526.39 | 152K | $9.9M |
| 2 | PTGXProtagonist Therapeutics | Healthcare | 4.59% | $459.01 | 69K | $8.6M |
| 3 | ALKSAlkermes | Healthcare | 4.43% | $443.12 | 180K | $8.3M |
| 4 | TFXTeleflex | Healthcare | 3.96% | $396.01 | 45K | $7.4M |
| 5 | SUPNSupernus | Healthcare | 3.37% | $336.53 | 223K | $6.3M |
| 6 | LGNDLigand Pharmaceuticals | Healthcare | 3.27% | $327.19 | 21K | $6.1M |
| 7 | MMSIMerit Medical Systems | Healthcare | 2.88% | $288.28 | 64K | $5.4M |
| 8 | RDNTRadNet | Healthcare | 2.82% | $281.59 | 76K | $5.3M |
| 9 | CONConcentra Group Parent | Healthcare | 2.81% | $281.16 | 127K | $5.3M |
| 10 | PTCTPTC Therapeutics | Healthcare | 2.78% | $278.43 | 90K | $5.2M |
| 11 | ICUIICU Medical | Healthcare | 2.51% | $251.40 | 27K | $4.7M |
| 12 | LQDALiquidia | Healthcare | 2.41% | $240.64 | 80K | $4.5M |
| 13 | LFSTLifeStance Health Group | Healthcare | 2.39% | $239.42 | 337K | $4.5M |
| 14 | AMRXAmneal Pharmaceuticals | Healthcare | 2.26% | $225.84 | 198K | $4.2M |
| 15 | OGNOrganon | Healthcare | 2.09% | $208.93 | 282K | $3.9M |
of the $108B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | TGTX | TG Therapeutics | 5.26% |
| 2 | PTGX | Protagonist Therapeutics | 4.59% |
| 3 | ALKS | Alkermes | 4.43% |
| 4 | TFX | Teleflex | 3.96% |
| 5 | SUPN | Supernus | 3.37% |
| 6 | LGND | Ligand Pharmaceuticals | 3.27% |
| 7 | MMSI | Merit Medical Systems | 2.88% |
| 8 | RDNT | RadNet | 2.82% |
| 9 | CON | Concentra Group Parent | 2.81% |
| 10 | PTCT | PTC Therapeutics | 2.78% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Mar 23, 2026 | Mar 27, 2026 | $0.0003 |
| Sep 22, 2025 | Sep 26, 2025 | $0.0026 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0020 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0142 |
| Dec 23, 2024 | Dec 27, 2024 | $0.0180 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0659 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0361 |
| Dec 18, 2023 | Dec 22, 2023 | $0.0045 |
| Sep 24, 2018 | Sep 28, 2018 | $0.0017 |
| Dec 16, 2016 | Dec 30, 2016 | $0.0065 |
| Dec 24, 2014 | Dec 31, 2014 | $0.48 |
| Dec 19, 2014 | Dec 31, 2014 | $0.0092 |